Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

Addressing stigma, inequity, and access to HIV innovations remains critical to progress in the global HIV response, says IAS ...

The World Health Organization (WHO) has certified the Government Pharmaceutical Organization's (GPO) facility in Pathum Thani ...

A new drug is hugely effective at protecting people from HIV infection and needs to be injected only twice a year.

The list prices of the top 25 drugs with the highest Medicare Part D spend that are not subject to drug price negotiations ...

Drugmakers have started 2025, implementing price hikes for 583 products within the first two days of the new year alone, ...

More than three years have passed since federal health officials arrived in central Appalachia to assess an alarming outbreak ...

Antiretroviral therapy, first introduced with the FDA’s approval of AZT in 1987, was a turning point in HIV treatment. Over 50 antiretroviral drugs are now FDA-approved, offering a range of ...

Top Medicare Part D drugs without price negotiations have seen a 98% increase in list prices since their launch. Read more ...

In 2018, the WHO approved GPO's request to register the drug on its list after ... living with HIV who have an undetectable viral load, using any WHO-prequalified combination of medications ...

French biotech Abivax might be on the verge of HIV cure and prevention discovery, after achieving a significant reduction of viral load patients during the first 28 days of treatment.